Colorectal cancer (CRC) is one of the most commonly diagnosed cancers worldwide and is an aggressive tumor with sobering prognosis. While chemotherapy remains the mainstay of current CRC treatment, it often incurs high medical cost and is often accompanied by numerous adverse side effects. Thus, CRC is clearly a disease for which alternative therapeutic methods must be developed. Consequently, the ultimate aim of this study is to build on our previous findings and move one step closer to the development of therapeutic and prophylactic methods for controlling CRC progression.

2023

2027